Skip to main content
. 2021 Sep 15;12:740517. doi: 10.3389/fimmu.2021.740517

Table 6.

Clinical presentations of IVIG-related adverse reactions.

ARs All patients Autoimmune diseases
All Neuromuscular diseases Other#
Patients
n = 37
Infusions
n = 102
Patients
n = 33
Infusions
n = 97
Patients
n = 19
Infusions
n = 65
Patients
n = 14
Infusions
n = 32
Headache 19 (51.4) 43 (42.2) 19 (57.6) 43 (44.3) 14 (73.7) 32 (49.2) 5 (35.7) 11 (34.4)
Fever 20 (54.1) 48 (47.1) 17 (51.6) 44 (45.4) 11 (57.9) 30 (46.2) 6 (42.9) 14 (43.8)
Flu-like symptoms 6 (16.2) 9 (8.8) 5 (15.2) 8 (8.2) 3 (15.8) 5 (7.7) 2 (14.3) 3 (9.4)
Hypertension 1 (2.7) 1 (1.0) 1 (3.0) 1 (1.0) 1 (7.1) 1 (3.1)
Dyspnea 1 (2.7) 1 (1.0) 1 (3.0) 1 (1.0) 1 (5.3) 1 (1.5)
Chest pain 2 (5.4) 2 (2.0) 2 (6.1) 2 (2.1) 2 (10.5) 2 (3.1)
Rash 4 (10.8) 4 (3.9) 3 (9.1) 3 (3.1) 3 (21.4) 3 (9.4)

ARs, adverse reactions. All table values are n (%).

#Other of autoimmune diseases are those without neuromuscular manifestations.